SCHEMBL22155478

SCHEMBL22155478

c1ccc(-c2cc3c4ccc5c6ccccc6c6cc(-c7ccc(-c8ccc9ccccc9c8)cc7)ccc6c5c4n(-c4ccccc4)c3c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 3/20 0.35
HSD17B2 P37059 3/20 0.35
ESR1 P03372 4/20 0.34
ESR2 Q92731 4/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
MTOR P42345 1/20 0.34
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
MPI P34949 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP17A1 P05093 1/20 0.31
CYP19A1 P11511 1/20 0.31
CYP11B1 P15538 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19786622 0.85 L3MBTL1 (0.34) HSD17B1HSD17B2ESR1ESR2PIK3CD
SCHEMBL18667710 0.82 ESR1 (0.39) HSD17B1HSD17B2ESR1ESR2PIK3CD
SCHEMBL18810640 0.81 KDM4E (0.45) HSD17B1HSD17B2ESR1ESR2PIK3CD
SCHEMBL21432023 0.81 HTR2B (0.39) KDM4EMEN1ALDH1A1MAPTHPGD
SCHEMBL20311875 0.81 KDM4E (0.35) CYP1A2CYP2C9CYP2C19KDM4EMEN1
SCHEMBL18810662 0.80 KDM4E (0.40) HSD17B1HSD17B2ESR1ESR2PIK3CD
SCHEMBL21035264 0.80 L3MBTL1 (0.37) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL20311878 0.80 KDM4E (0.36) CYP1A2CYP2C9CYP2C19KDM4EMEN1
SCHEMBL20312115 0.80 HSD17B1 (0.35) HSD17B1HSD17B2ESR1ESR2PIK3CD
SCHEMBL18810613 0.79 L3MBTL1 (0.38) HSD17B1HSD17B2ESR1ESR2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11296282-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-04-05 US disclosed
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11296282-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, EML4, SLCO2A1 HSD17B1 2905/4885HSD17B2 2842/4885ESR1 728/4885
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, EML4, SLCO2A1 HSD17B1 2905/4885HSD17B2 2842/4885ESR1 728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.